Twelve-month mental health service use in six countries of the Americas: A regional report from the World Mental Health Surveys

Carregando...
Imagem de Miniatura
Citações na Scopus
25
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
CAMBRIDGE UNIV PRESS
Autores
BORGES, G.
AGUILAR-GAXIOLA, S.
BENJET, C.
CIA, A.
KESSLER, R. C.
OROZCO, R.
SAMPSON, N.
STAGNARO, J. C.
TORRES, Y.
Citação
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, v.29, article ID e53, 15p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Aims. To provide cross-national data for selected countries of the Americas on service utilization for psychiatric and substance use disorders, the distribution of these services among treatment sectors, treatment adequacy and factors associated with mental health treatment and adequacy of treatment. Methods. Data come from data collected from 6710 adults with 12 month mental disorder surveys across seven surveys in six countries in North (USA), Central (Mexico) and South (Argentina, Brazil, Colombia, Peru) America who were interviewed 2001-2015 as part of the World Health Organization (WHO) World Mental Health (WMH) Surveys. DSM-IV diagnoses were made with the WHO Composite International Diagnostic Interview (CIDI). Interviews also assessed service utilization by the treatment sector, adequacy of treatment received and socio-demographic correlates of treatment. Results. Little over one in four of respondents with any 12 month DSM-IV/CIDI disorder received any treatment. Although the vast majority (87.1%) of this treatment was minimally adequate, only 35.3% of cases received treatment that met acceptable quality guidelines. Indicators of social-advantage (high education and income) were associated with higher rates of service use and adequacy, but a number of other correlates varied across survey sites. Conclusions. These results shed light on an enormous public health problem involving under-treatment of common mental disorders, although the problem is most extreme among people with social disadvantage. Promoting services that are more accessible, especially for those with few resources, is urgently needed.
Palavras-chave
Epidemiology, mental health, service use, transcultural
Referências
  1. Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5
  2. Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21
  3. Alonso J, 2018, BURDENS MENTAL DISOR
  4. American Psychiatric Association, 1997, PRACT GUID TREATM PA
  5. American Psychiatric Association, 1998, PRACTICE GUIDELINE T
  6. American Psychiatric Association, 2000, PRACTICE GUIDELINE T, V2
  7. American Psychiatric Association, 1994, PRACTICE GUIDELINE T
  8. Borges G, 2006, AM J PSYCHIAT, V163, P1371, DOI 10.1176/appi.ajp.163.8.1371
  9. Burnham K.P., 2002, MODEL SELECTION MULT, V2nd ed.
  10. Stagnaro JC, 2018, SOC PSYCH PSYCH EPID, V53, P121, DOI 10.1007/s00127-017-1475-9
  11. Costa ND, 2011, CIENC SAUDE COLETIVA, V16, P4603
  12. Degenhardt L, 2017, WORLD PSYCHIATRY, V16, P299, DOI 10.1002/wps.20457
  13. Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581
  14. ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766
  15. Evans-Lacko S, 2018, PSYCHOL MED, V48, P1560, DOI 10.1017/S0033291717003336
  16. Heeringa SG, 2008, SAMPLE DESIGNS SAMPL, P14
  17. HOSMER DW, 2000, WILEY PS TX, P1
  18. Judd F, 2008, AUST NZ J PSYCHIAT, V42, P24, DOI 10.1080/00048670701732681
  19. Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
  20. Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
  21. Kohn R, 2014, BRECHA TRATAMIENTO R
  22. Lehman AF, 1998, SCHIZOPHRENIA B, V24
  23. Mateus Mario D, 2008, Int J Ment Health Syst, V2, P12, DOI 10.1186/1752-4458-2-12
  24. Mortier P, 2018, J AM ACAD CHILD PSY, V57, P263, DOI 10.1016/j.jaac.2018.01.018
  25. National Committee for Quality Assurance, 1999, HEDIS 2000 TECHN SPE
  26. Panel DG, 1993, AGENCY HLTH CARE POL
  27. Piazza Marina, 2014, Rev. perú. med. exp. salud publica, V31, P30
  28. Posada-Villa José A., 2004, rev.colomb.psiquiatr., V33, P241
  29. Research Triangle Park NC, 2002, REL 8 0 1
  30. ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069
  31. Rodriguez JP, 2007, COST OF INSTITUTIONS: INFORMATION AND FREEDOM IN EXPANDING ECONOMIES, P15
  32. Seidler ZE, 2016, CLIN PSYCHOL REV, V49, P106, DOI 10.1016/j.cpr.2016.09.002
  33. Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015
  34. STURM R, 1995, JAMA-J AM MED ASSOC, V273, P51
  35. The World Bank, 2018, GINI IND WORLD BANK
  36. Thornicroft G, 2017, BRIT J PSYCHIAT, V210, P119, DOI 10.1192/bjp.bp.116.188078
  37. Torres de Galvis Y, 2012, PRIMER ESTUDIO POBLA
  38. Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
  39. Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7
  40. Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629
  41. Wang PS, 2002, AM J PUBLIC HEALTH, V92, P92, DOI 10.2105/AJPH.92.1.92
  42. Wang YP, 2017, EPIDEMIOL PSYCH SCI, V26, P89, DOI 10.1017/S2045796016000202
  43. WHO AIMS, 2013, INF REG SIST SAL MEN
  44. Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55